Weihong Xu
- Topics
- Inflammasome and immune disorders (3 papers)RNA modifications and cancer (3 papers)Autophagy in Disease and Therapy (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Weihong Xu
17 papers receiving 483 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 280
- Epidemiology 170
- Cancer Research 83
- Oncology 61
- Cell Biology 59
Countries citing papers authored by Weihong Xu
This map shows the geographic impact of Weihong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihong Xu more than expected).
Fields of papers citing papers by Weihong Xu
This network shows the impact of papers produced by Weihong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihong Xu. The network helps show where Weihong Xu may publish in the future.
Co-authorship network of co-authors of Weihong Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Weihong Xu. A scholar is included among the top collaborators of Weihong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihong Xu. Weihong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 13 | |
| 7 | 60 | |
| 8 | 2 | |
| 9 | 21 | |
| 10 | 26 | |
| 11 | 35 | |
| 12 | 14 | |
| 13 | 3 | |
| 14 | 10 | |
| 15 | 10 | |
| 16 | Overexpression and biological function of IQGAP3 in human pancreatic cancer. | 33 |
| 17 | 14 | |
| 18 | 2 | |
| 19 | 52 | |
| 20 | 180 |
About Weihong Xu
Weihong Xu is a scholar working on Periodontics, Cancer Research and Endocrinology, having authored 20 papers that have together received 489 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (3 papers), RNA modifications and cancer (3 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Cancer Research (83 citations), Epidemiology (170 citations) and Molecular Biology (280 citations). Weihong Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Haiyan Qi, Shengkan Jin, Yong Zhang, Bill Taylor, Leroy F. Liu, Huiming Sheng, Yanyun Ma, Jiucun Wang, Guihua Wang and Xiaoling Lv. Their work appears in journals such as Cancer Research, Biochemical and Biophysical Research Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.